Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX1 | hg38_v1_chr13_+_112067143_112067160 | 0.09 | 6.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_95069489 Show fit | 1.51 |
ENST00000371270.6
ENST00000535898.5 ENST00000623108.3 |
cytochrome P450 family 2 subfamily C member 8 |
|
chr16_+_11965193 Show fit | 0.89 |
ENST00000053243.6
ENST00000396495.3 |
TNF receptor superfamily member 17 |
|
chr4_+_68815991 Show fit | 0.69 |
ENST00000265403.12
ENST00000458688.2 |
UDP glucuronosyltransferase family 2 member B10 |
|
chrX_+_106168297 Show fit | 0.68 |
ENST00000337685.6
ENST00000357175.6 |
PWWP domain containing 3B |
|
chr19_+_35351552 Show fit | 0.68 |
ENST00000246553.3
|
free fatty acid receptor 1 |
|
chr11_-_47378479 Show fit | 0.64 |
ENST00000533968.1
|
Spi-1 proto-oncogene |
|
chr16_+_11965234 Show fit | 0.62 |
ENST00000562385.1
|
TNF receptor superfamily member 17 |
|
chr3_-_58214671 Show fit | 0.54 |
ENST00000460422.1
ENST00000483681.5 |
deoxyribonuclease 1 like 3 |
|
chr3_-_171771295 Show fit | 0.53 |
ENST00000418087.1
|
phospholipase D1 |
|
chr1_-_144456805 Show fit | 0.51 |
ENST00000581897.6
ENST00000577412.5 |
NBPF member 15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 1.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.2 | 1.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.0 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.4 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.1 | 0.4 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.0 | 0.2 | GO:0097229 | sperm end piece(GO:0097229) |
0.0 | 0.2 | GO:0097545 | axonemal outer doublet(GO:0097545) |
0.0 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 0.1 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.5 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 1.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.7 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.0 | 0.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |